摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

barium formate | 541-43-5

分子结构分类

中文名称
——
中文别名
——
英文名称
barium formate
英文别名
barium(2+);formate
barium formate化学式
CAS
541-43-5
化学式
Ba*2CHO2
mdl
——
分子量
227.365
InChiKey
LDVLRBJTSWYKHL-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    3.21
  • 溶解度:
    溶于H2O;不溶于乙醇

计算性质

  • 辛醇/水分配系数(LogP):
    -2.01
  • 重原子数:
    4.0
  • 可旋转键数:
    0.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    40.13
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

安全信息

  • 安全说明:
    S28
  • 危险类别码:
    R20/22
  • 危险品运输编号:
    UN 1564

SDS

SDS:b6ab3b60c427f12ebd9de6a57015b7c9
查看

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Fischer,F.; Tropsch; Schellenberg, Gesammelte Abhandlungen zur Kenntnis der Kohle, vol. 6, p. 356
    摘要:
    DOI:
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 作用下, 125.0 ℃ 、19.61 MPa 条件下, 生成 barium formate
    参考文献:
    名称:
    卡塔尔蒂什模还原冯·埃尔达卡利碳酸氢盐和瓦瑟斯托夫
    摘要:
    可以从Wasserstoff和Kohlendioxyddruck处还原碳酸氢钙,而在其他情况下则不能使用。统一选举法。
    DOI:
    10.1002/hlca.19550380533
  • 作为试剂:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 barium formate 作用下, 生成 十六醛
    参考文献:
    名称:
    Krafft, Chemische Berichte, 1880, vol. 13, p. 1415
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Atherogenic High-Fat Diet Reduces Bone Mineralization in Mice
    作者:Farhad Parhami、Yin Tintut、Wesley G. Beamer、Nima Gharavi、William Goodman、Linda L. Demer
    DOI:10.1359/jbmr.2001.16.1.182
    日期:——
    The epidemiological correlation between osteoporosis and cardiovascular disease is independent of age, but the basis for this correlation is unknown. We previously found that atherogenic oxidized lipids inhibit osteoblastic differentiation in vitro and ex vivo, suggesting that an atherogenic diet may contribute to both diseases. In this study, effects of an atherogenic high‐fat diet versus control chow diet on bone were tested in two strains of mice with genetically different susceptibility to atherosclerosis and lipid oxidation. After 4 months and 7 months on the diets, mineral content and density were measured in excised femurs and lumbar vertebrae using peripheral quantitative computed tomographic (pQCT) scanning. In addition, expression of osteocalcin in marrow isolated from the mice after 4 months on the diets was examined. After 7 months, femoral mineral content in C57BL/6 atherosclerosis‐susceptible mice on the high‐fat diet was 43% lower (0.73 ± 0.09 mg vs. 1.28 ± 0.42 mg; p = 0.008), and mineral density was 15% lower compared with mice on the chow diet. Smaller deficits were observed after 4 months. Vertebral mineral content also was lower in the fat‐fed C57BL/6 mice. These changes in the atherosclerosis‐resistant, C3H/HeJ mice were smaller and mostly not significant. Osteocalcin expression was reduced in the marrow of high fat‐fed C57BL/6 mice. These findings suggest that an atherogenic diet inhibits bone formation by blocking differentiation of osteoblast progenitor cells.
    骨质疏松症和心血管疾病之间的流行病学关联与年龄无关,但其基础尚不清楚。我们之前发现致动脉粥样硬化氧化脂质在体外和体内抑制成骨细胞分化,暗示致动脉粥样硬化饮食可能对这两种疾病都有贡献。在这项研究中,测试了致动脉粥样硬化高脂肪饮食与对照饲料饮食对两种遗传性动脉粥样硬化和脂质氧化敏感性不同的小鼠骨骼的影响。在饮食4个月和7个月后,使用外周定量计算机断层扫描(pQCT)扫描测量切除的股骨和腰椎的矿物质含量和密度。此外,在饮食4个月后从小鼠骨髓中检测骨素的表达。7个月后,高脂肪饮食的C57BL/6动脉粥样硬化敏感小鼠的股骨矿物质含量降低43%(0.73 ± 0.09 mg vs. 1.28 ± 0.42 mg; p = 0.008),矿物质密度降低15%,与饲料饮食的小鼠相比。4个月后观察到的缺陷较小。脂肪喂养的C57BL/6小鼠的椎骨矿物质含量也较低。这些变化在抗动脉粥样硬化的C3H/HeJ小鼠中较小,多数不显著。高脂肪喂养的C57BL/6小鼠的骨髓中骨素表达降低。这些发现表明,致动脉粥样硬化饮食通过阻断成骨细胞前体细胞的分化来抑制骨骼形成。
  • METHOD FOR PRODUCING FORMIC ACID
    申请人:Nakahara Masaru
    公开号:US20120295991A1
    公开(公告)日:2012-11-22
    An object of the present invention is providing a method for producing formic acid under mild reaction conditions and by a simple procedure. As a means for achieving the object, the method for producing formic acid of the present invention is characterized by a reaction between carbon dioxide and hydrogen in the presence of an ionic liquid. According to the present invention, it is possible to generate formic acid effectively, because the method does not require that carbon dioxide be brought into a supercritical state and because no basic substances are required to be added to the reaction system.
    本发明的一个目的是提供一种在温和反应条件下通过简单程序生产甲酸的方法。为了实现这一目的,本发明的生产甲酸方法的特点是在离子液体的存在下,碳酸气体和氢气之间发生反应。根据本发明,由于该方法不需要将二氧化碳置于超临界状态,也不需要向反应系统中添加碱性物质,因此可以有效生成甲酸
  • Consistency of NMR and Mass Spectrometry Determinations of Natural-Abundance Site-Specific Carbon Isotope Ratios. The Case of Glycerol
    作者:Ben-Li Zhang、Michel Trierweiler、Catherine Jouitteau、Gérard J. Martin
    DOI:10.1021/ac9812375
    日期:1999.7.1
    techniques. To have access to site-specific isotope ratios by IRMS, the products have been degraded and transformed into two derivatives, one of which contains carbons 1 and 3 and the other carbon 2 of glycerol. The sensitivity of the isotopic parameters determined by IRMS to fractionation effects possibly occurring in the course of the chemical transformations has been investigated, and the repeatability
    通过核磁共振(SNIF-NMR)天然丰度的碳同位素比率的定量测定已通过实验条件适当选择,并通过基于专用算法信号分析而优化。为了检查通过NMR和质谱(IRMS)获得的同位素值的一致性,已经通过两种技术研究了相同的甘油样品。为了通过IRMS获得特定位置的同位素比率,已将产物降解并转化为两种衍生物,其中一种含有甘油的碳1和3,另一种含有甘油的碳2。已经研究了由IRMS确定的同位素参数对化学转化过程中可能发生的分馏效应的敏感性,并且估计了两个分析链的可重复性和可重复性。在两个系列的同位素结果之间观察到的良好一致性支持了两种不同方法的可靠性。因此,SNIF-NMR是一种非常诱人的工具,可用于在单个非破坏性实验中常规测定甘油中碳同位素的分布,该方法可应用于其他化合物。使用这种方法,比较了从植物或动物油中提取,从发酵培养基中提取或通过化学合成制备的甘油样品的同位素分布。典型行为被表征。因此,SNIF-N
  • Synthesis and characterization of dibarium iron(II) formate tetrahydrate
    作者:Violeta Z Vassileva
    DOI:10.1016/s0040-6031(02)00398-2
    日期:2003.3
    Abstract The Ba(HCOO) 2 –Fe(HCOO) 2 –H 2 O system has been studied by the solubility method at 25 °C and formation of a new double salt with composition Ba 2 Fe(HCOO) 6 ·4H 2 O was established. The double salt has been characterized by X-ray powder diffraction and thermal analysis. Ba 2 Fe(HCOO) 6 ·4H 2 O is isostructural with the double salts Ba 2 Me(HCOO) 6 ·4H 2 O (Me=Co, Ni, Cu, and Zn) and crystallizes
    摘要 用溶解度法研究了 Ba(HCOO) 2 -Fe(HCOO) 2 -H 2 O 体系,在 25 °C 下形成了一种新的复盐,其组成为 Ba 2 Fe(HCOO) 6 ·4H 2 O已确立的。该复盐已通过 X 射线粉末衍射和热分析表征。Ba 2 Fe(HCOO) 6 ·4H 2 O 与复盐 Ba 2 Me(HCOO) 6 ·4H 2 O(Me=Co、Ni、Cu 和 Zn)同构,在三斜晶系(空间群 P 1 ) 晶格参数 a =8.902(3) A, b =7.125(2) A, c =6.901(3) A, α =98.85(5)°, β =108.81(4)°, γ =82.47( 3)°。在较低的加热速率下,通过 DSC 确定了复盐热脱过程中存在两个步骤。脱焓已确定。
  • Structural refinements of eulytite-type Ca3Bi(PO4)3 and Ba3La(PO4)3
    作者:Jacques Barbier
    DOI:10.1016/0022-4596(92)90181-t
    日期:1992.12
    The room-temperature structures of the eulytite compounds Ca3Bi(PO4)3 and Ba3La(PO4)3 have been refined using powder neutron diffraction data. The metal atoms are disordered on a single site of the space group, whereas the oxygen atoms are split between two sites, giving rise to rotational disorder of the phosphate anion similar to that previously observed in Sr3La(PO4)3. The degree of oxygen disorder
    所述eulytite的室温的结构的化合物的Ca 3的Bi(PO 4)3和Ba 3的La(PO 4)3使用粉末中子衍射数据已经细化。属原子无序上的单个位点的空间群,而氧原子在两个站点之间分裂,从而产生磷酸根阴离子的转动无序类似于先前在高级观察到3的La(PO 4)3。氧病症的程度取决于属原子的性质,特别是,当Bi的减少3+离子存在于eulytite结构。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯